EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS

Objective. To evaluate the efficacy, tolerability and safety of the drug Diacerein (Artrocker) in patients with osteoarthritis (OA) of the hip joints after continuous administration for 4 months and the duration of the drug effects for 2 months. Materials and methods. The study included 30 patients...

Full description

Bibliographic Details
Main Authors:	E. P. Sharapova, N. G. Kashevarova, E. M. Zaytseva, S. G. Anikin, T. A. Korotkova, L. I. L.I. Alexeeva
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-12-01
Series:	Медицинский совет
Subjects:	osteoarthritis, pain diacerein clinical efficacy tolerability adverse events
Online Access:	https://www.med-sovet.pro/jour/article/view/1666

Similar Items

NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME
by: L. I. Alexeeva, et al.
Published: (2018-02-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY
by: L. I. Alekseeva, et al.
Published: (2018-05-01)

Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice
by: Andrey E. Karateev, et al.
Published: (2023-05-01)

Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis
by: Fan Zeng, et al.
Published: (2023-04-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

Diacerein-Loaded Hyaluosomes as a Dual-Function Platform for Osteoarthritis Management via Intra-Articular Injection: In Vitro Characterization and In Vivo Assessment in a Rat Model
by: Nouran O. Eladawy, et al.
Published: (2021-05-01)

Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial
by: Andrei E. Karateev, et al.
Published: (2021-05-01)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
by: Basma Mostafa Zaki, et al.
Published: (2015-09-01)

Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS)
by: Guoqi Cai, et al.
Published: (2022-09-01)

PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
by: Raju Rameshrao Thenge, et al.
Published: (2017-01-01)

USE OF DRUGS ARTHRA MSM FORTE AND ARTHRA FOR OSTEOARTHRITIS AND BACK PAINS
by: L. I. Alekseeva, et al.
Published: (2017-05-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Development of composition and evaluation of equivalence of diacerein hard gelatin capsules
by: O. O. Saliy, et al.
Published: (2021-12-01)

Topical Diacerein Decreases Skin and Splenic CD11c<sup>+</sup> Dendritic Cells in Psoriasis
by: Susanne M. Brunner, et al.
Published: (2023-02-01)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
by: Chunyan Fu, et al.
Published: (2023-08-01)

Diacerein in the treatment of chronic plaque psoriasis: A case report
by: Kalgi Baxi, et al.
Published: (2022-01-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)

Differential scanning calorimetry: A screening tool for the development of diacerein eutectics
by: Rajeshri D. Patel, et al.
Published: (2022-01-01)

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model
by: Shunbo Shi, et al.
Published: (2020-09-01)

Validated determination of diacerein and its active metabolite, rhein, by stability indicating constant pattern method as a novel manipulation of zero order spectra
by: Aml A. Emam, et al.
Published: (2018-06-01)

The effect of food intake on the pk of rhein released from diacerein
by: Ming Huang, et al.
Published: (2020-04-01)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
by: Miriam Méndez-del Villar, et al.
Published: (2017-02-01)

Corneal pharmacokinetics of the 2% diacerein eye drops between multiple administration and single administration
by: Ke Yang, et al.
Published: (2018-04-01)

Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
by: Allam AN, et al.
Published: (2017-07-01)

CLINICAL AND SONOGRAPHIC ASSESSMENT OF SYNOVITIS ACTIVITY IN PATIENTS WITH KNEE OSTEOARTHRITIS DURING THERAPY
by: A. V. Petrov, et al.
Published: (2016-02-01)

Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice
by: Guangzhe Yu, et al.
Published: (2018-08-01)

Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation
by: Diana E. Aziz, et al.
Published: (2018-01-01)

Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials
by: Chun-Ru Lin, et al.
Published: (2023-09-01)

Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
by: Brunella Grassiri, et al.
Published: (2023-02-01)

Pain type in osteoarthritis. Approaches to treatment
by: R.M. Balabanova
Published: (2014-05-01)

Use of ARTRA MSM FORTE in patients with knee osteoarthritis: Results of a randomized open-label comparative study of the efficacy and tolerability of the drug
by: L I Alekseeva, et al.
Published: (2015-12-01)

Interleukin-6 expression and its modulation by diacerein in a rat model of chronic stress induced cardiac dysfunction
by: Vipul Agarwal, et al.
Published: (2021-12-01)

Topiramate Effectiveness as Add-on Therapy in Bulgarian Patients with Drug-resistant Epilepsy
by: Ekaterina Viteva, et al.
Published: (2020-12-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

Comparison of continuous and intermittent treatment of patients with knee osteoarthritis with combined drug “Teraflex”
by: L I Alexeeva, et al.
Published: (2008-06-01)